Faruqi and Faruqui, LLP Logo
Share this page

Cases

Page 2 of 87 (1734 Items)
11
Jan
2017

Novo Nordisk A/S (NVO)

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Novo Nordisk A/S To Contact The Firm Before Lead Plaintiff Deadline Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Novo Nordisk A/S (“Novo Nordisk” or the “Company”) (NYSE:NVO) of the... READ MORE

09
Jan
2017

Agile Therapeutics, Inc. (AGRX)

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $50,000 Investing In Agile Therapeutics, Inc. To Contact The Firm Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Agile Therapeutics, Inc. (“Agile” or the “Company”) (NASDAQ:AGRX). The investigation focuses on... READ MORE

09
Jan
2017

American Renal Associates Holdings, Inc. (ARA)

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In American Renal Associates Holdings, Inc. To Contact The Firm Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at American Renal Associates Holdings, Inc. (“American Renal” or the “Company”)... READ MORE

09
Jan
2017

DaVita Inc. (DVA)

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In DaVita Inc. To Contact The Firm Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at DaVita Inc. (“DaVita” or the “Company”) (NYSE:DVA). The investigation focuses on whether the... READ MORE

06
Jan
2017

Sinovac Biotech Ltd. (SVA)

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Sinovac Biotech Ltd. To Contact The Firm Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Sinovac Biotech Ltd. (“Sinovac” or the “Company”) (NASDAQ:SVA). The investigation focuses on... READ MORE

06
Jan
2017

Live Ventures Inc. (LIVE)

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Live Ventures Inc. To Contact The Firm Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Live Ventures Inc. (“Live Ventures” or the “Company”) (NASDAQ:LIVE). The investigation focuses... READ MORE

06
Jan
2017

CEB Inc. (CEB)

Faruqi & Faruqi, LLP Announces the Investigation of CEB Inc. (CEB) Over the Proposed Sale of the Company to Gartner Inc. Nadeem Faruqi, founding partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of CEB Inc. (“CEB”... READ MORE

06
Jan
2017

Inotek Pharmaceuticals Corporation (ITEK)

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Inotek Pharmaceuticals Corporation To Contact The Firm Before Lead Plaintiff Deadline Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Inotek Pharmaceuticals Corporation (“Inotek” or the “Company”) (NASDAQ:ITEK) of the March... READ MORE

06
Jan
2017

TG Therapeutics, Inc. (TGTX)

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In TG Therapeutics, Inc. To Contact The Firm Before Lead Plaintiff Deadline Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in TG Therapeutics, Inc.  (“TG” or the “Company”) (NASDAQ:TGTX) of the March... READ MORE

05
Jan
2017

Endologix, Inc. (ELGX)

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Endologix, Inc. To Contact The Firm Before Lead Plaintiff Deadline Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Endologix, Inc. (“Endologix” or the “Company”) (NASDAQ:ELGX) of the March 6, 2017... READ MORE

03
Jan
2017

UnitedHealth Group Incorporated (UNH)

Faruqi & Faruqi, LLP is Investigating UnitedHealth Group Incorporated (UNH) on Behalf of its Shareholders Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential misconduct at UnitedHealth Group Incorporated (“United Health” or the “Company”) (NYSE:UNH). The investigation focuses on whether the Company’s Board of Directors and... READ MORE

27
Dec
2016

Rent-A-Center, Inc. (RCII)

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Rent-A-Center, Inc. To Contact The Firm Before Lead Plaintiff Deadline Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Rent-A-Center, Inc. (“Rent-A-Center” or the “Company”) (NASDAQ:RCII) of the February 21, 2017... READ MORE

27
Dec
2016

Universal Health Services, Inc. (UHS)

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $250,000 Investing In Universal Health Services, Inc. To Contact The Firm Before Lead Plaintiff Deadline Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Universal Health Services, Inc. (“Universal Health” or the “Company”) (NYSE:UHS)... READ MORE

20
Dec
2016

Abeona Therapeutics Inc. (ABEO)

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Abeona Therapeutics Inc. To Contact The Firm Before Lead Plaintiff Deadline Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Abeona Therapeutics Inc. (“Abeona” or the “Company”) (NASDAQ:ABEO), formerly known as... READ MORE

19
Dec
2016

Taro Pharmaceutical Industries Ltd. (TARO)

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Taro Pharmaceutical Industries Ltd. To Contact The Firm Before Imminent Lead Plaintiff Deadline Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Taro Pharmaceutical Industries Ltd. (“Taro” or the “Company”) (NYSE:TARO)... READ MORE

19
Dec
2016

Illumina, Inc. (ILMN)

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Illumina, Inc. To Contact The Firm Before Lead Plaintiff Deadline Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Illumina, Inc. (“Illumina” or the “Company”) (NASDAQ:ILMN) of the February 14, 2017... READ MORE

16
Dec
2016

Monaker Group, Inc. (MKGI)

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Monaker Group, Inc. To Contact The Firm Before Lead Plaintiff Deadline Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Monaker Group, Inc.  (“Monaker” or the “Company”) (OTC:MKGI) of the February... READ MORE

16
Dec
2016

Rio Tinto plc (RIO)

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Rio Tinto plc To Contact The Firm Before Lead Plaintiff Deadline Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Rio Tinto plc  (“Rio Tinto” or the “Company”) (NYSE:RIO) of the... READ MORE

12
Dec
2016

J.C. Penny Company, Inc. (JCP)

Faruqi & Faruqi, LLP is Investigating J.C. Penny Company, Inc. (JCP) on Behalf of its Shareholders Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential misconduct at J.C. Penny Company, Inc. (“J.C. Penny” or the “Company”) (NYSE:JCP). The investigation focuses on whether the Company’s Board of... READ MORE

09
Dec
2016

CLARCOR Inc. (CLC)

Faruqi & Faruqi, LLP Announces the Investigation of CLARCOR Inc. (CLC) Over the Proposed Sale of the Company to Parker Hannifin Corporation Nadeem Faruqi, founding partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of CLARCOR Inc.... READ MORE

Page 2 of 87 (1734 Items)